Search

Displaying results 7001 - 7010 of 10000 in total
  1. Drug

    Coagulin-B

    go.drugbank.com/drugs/DB17703
    Experimental

    [A259038, A259043] It was previously investigated for the treatment of hemophilia; however, the manufacturing company discontinued the Phase I trial in 2004, halting its further development and investigation … Coagulin-B is an adeno-associated viral vector expressing human blood-coagulation Factor IX.

  2. Drug

    Tandamine

    go.drugbank.com/drugs/DB09192
    Experimental

    Tandamine was researched in 1970s as an antidepressant but was never commercialized. Tandamine is an analog of pirandamine and it acts as a selective serotonin reuptake inhibitor (SSRI).

  3. Drug

    ASF-1075

    go.drugbank.com/drugs/DB05727
    Experimental

  4. Drug

    EMD-1201081

    go.drugbank.com/drugs/DB06181
    Investigational

  5. Drug

    Repifermin

    go.drugbank.com/drugs/DB06434
    Experimental

  6. Drug

    Edifoligide

    go.drugbank.com/drugs/DB06556
    Investigational

  7. Drug

    Regrelor

    go.drugbank.com/drugs/DB05553
    Investigational

  8. Drug

    PRX-08066

    go.drugbank.com/drugs/DB05607
    Investigational

  9. Drug

    Medetomidine

    go.drugbank.com/drugs/DB11428
    ExperimentalVet approved

    In the United States, it is currently approved for its veterinary use in dogs and distributed by Pfizer Animal Health. In Canada, medetomidine is distributed by Novartis Animal Health. … Medetomidine is a synthetic compound used as a surgical anesthetic and analgesic. It is normally found as its hydrochloride salt, medetomidine hydrochloride.

  10. Drug

    Ofirnoflast

    go.drugbank.com/drugs/DB21679
    Investigational

    Ofirnoflast is under investigation in clinical trial NCT07052006 (HT-6184 in Subjects With MDS). Ofirnoflast has a monoisotopic molecular weight of 501.15 Da. … Ofirnoflast is a small molecule drug. The usage of the INN stem '-noflast' in the name indicates that Ofirnoflast is a inflammasome protein NLRP3 inhibitor.